Boston Scientific (BSX) Tops Q1 EPS by 5c; Guides Above Views
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $44.92 +2.74%
EPS Growth %: +5.3%
Financial Fact:
Gross profit: 1.51B
Today's EPS Names:
NEOV, MANU, CTAS, More
EPS Growth %: +5.3%
Financial Fact:
Gross profit: 1.51B
Today's EPS Names:
NEOV, MANU, CTAS, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q1 EPS of $0.56, $0.05 better than the analyst estimate of $0.51. Revenue for the quarter came in at $3.86 billion versus the consensus estimate of $3.68 billion.
GUIDANCE:
Boston Scientific sees Q2 2024 EPS of $0.57-$0.59, versus the consensus of $0.56.
Boston Scientific sees FY2024 EPS of $2.29-$2.34, versus the consensus of $2.25.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Jefferies Starts China Oilfield Services (2883:HK) (CHOLF) at Buy
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
